Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dennis J. Purcell currently holds 2,054,594 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dennis J. Purcell has been a net buyer of ESPR stock. They have purchased $20.6M and sold $0 worth of shares.
Dennis J. Purcell's most recent insider trade was on Jul 1, 2013, when they purchased 238,119 shares at $14.00 per share.
Dennis J. Purcell serves as Executive at Esperion Therapeutics, Inc. (ESPR). They have executed 4 insider transactions totaling $20.6M over their tenure at the company.
Dennis J. Purcell holds the position of Executive at Esperion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Dennis J. Purcell has shown a buying trading pattern, with $20.6M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Dennis J. Purcell was on Oct 24, 2011, when they purchased $10.0M worth of ZLTQ shares. This transaction involved 769,231 shares at $13.00 per share.
Dennis J. Purcell currently owns 2,054,594 shares of Esperion Therapeutics, Inc. (ESPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dennis J. Purcell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dennis J. Purcell has 4 Form 4 filings on record as an insider at Esperion Therapeutics, Inc..
Set alerts for Dennis J. Purcell and 40,000+ other insiders.